{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:27:48Z","timestamp":1785511668368,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/TDT\/TC\/Rare\/2022\/21(G)\/1"],"award-info":[{"award-number":["DST\/TDT\/TC\/Rare\/2022\/21(G)\/1"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/TDT\/TC\/Rare\/2022\/21(G)\/1"],"award-info":[{"award-number":["DST\/TDT\/TC\/Rare\/2022\/21(G)\/1"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rare\u00a0diseases refer to a group of neglected diseases with low prevalence that face challenges in diagnostics as well as therapeutics due to phenotypic heterogeneity and ineffective clinical trials. In this study, we evaluated two novel analogs of hydroxyethylamine &amp; phthalimide (LTC-181 and LTC-1717) for their potential effect on the epimerase activity of mutant GNE proteins associated with GNE myopathy. GNE gene encodes a key bifunctional sialic acid biosynthetic enzyme, UDP-N-acetyl Glucosamine 2-epimerase\/N-acetyl Mannosamine Kinase; GNE). The compounds have significantly increased the epimerase activity of r-F307C-GNE and r-A555V-GNE mutant proteins in vitro. Reduced GNE epimerase activity and sialic acid content in muscle cell-based model for GNE function (SKM-GNEHz) was increased by 2-fold after addition of these compounds. The proteomic study showed that the compounds affected cytoskeletal organization, autophagy and muscle atrophy. Also, treatment with analogs enhanced the cell viability of SKM-GNEHz cells with increased F-actin polymerization and cell migration, thereby, restoring GNE deficient function. Additionally, effect of these compounds was observed with enhanced autophagy and reduced muscle atrophy function in GNE deficient muscle cell. Docking and interaction studies showed that LTC-1717 stabilize GNE better than LTC-181, indicating better therapeutic potential. Overall, this study indicates that HEA-phthalimide analog could be promising leads for treating GNE myopathy.<\/jats:p>","DOI":"10.1186\/s10020-025-01377-1","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:37:21Z","timestamp":1764740241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hydroxyethylamine &amp; phthalimide analogs restoring defects due to GNE dysfunction: rare disease therapeutic significance"],"prefix":"10.1186","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0843-385X","authenticated-orcid":false,"given":"Shagun","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9158-6702","authenticated-orcid":false,"given":"Vikas","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3154-3484","authenticated-orcid":false,"given":"Fluencephila","family":"Mashangva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7760-760X","authenticated-orcid":false,"given":"Jyoti","family":"Oswalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan Deep","family":"Jhingan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1720-2165","authenticated-orcid":false,"given":"Naidu","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2133-8847","authenticated-orcid":false,"given":"Brijesh","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-9351","authenticated-orcid":false,"given":"Ranjana","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"publisher","unstructured":"Abraham MJ, Murtola T, Schulz R et al. (2015) Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001.","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"1377_CR2","doi-asserted-by":"publisher","first-page":"e2477","DOI":"10.1371\/journal.pone.0002477","volume":"3","author":"S Amsili","year":"2008","unstructured":"Amsili S, Zer H, Hinderlich S, et al. UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase (GNE) binds to alpha-actinin 1: novel pathways in skeletal muscle? PLoS ONE. 2008;3:e2477.","journal-title":"PLoS ONE"},{"key":"1377_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03134-z","author":"J Benjamin-Chung","year":"2024","unstructured":"Benjamin-Chung J, Li H, Nguyen A, et al. Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects. Nat Med. 2024. https:\/\/doi.org\/10.1038\/s41591-024-03134-z.","journal-title":"Nat Med"},{"key":"1377_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pep.2004.02.013","volume":"35","author":"A Blume","year":"2004","unstructured":"Blume A, Ghaderi D, Liebich V, et al. UDP-N-acetylglucosamine2-epimerase\/N-acetylmannosamine kinase, functionally expressed in and purified from Escherichia coli, yeast, and insect cells. Protein Expr Purif. 2004;35:387\u201396. https:\/\/doi.org\/10.1016\/j.pep.2004.02.013.","journal-title":"Protein Expr Purif"},{"key":"1377_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000890","author":"M Chakraborty","year":"2022","unstructured":"Chakraborty M, Choudhury MC, Chakraborty I, Saberwal G. Rare disease patients in India are rarely involved in international orphan drug trials. PLoS Glob Public Health. 2022. https:\/\/doi.org\/10.1371\/journal.pgph.0000890.","journal-title":"PLoS Glob Public Health"},{"key":"1377_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-017-8467-5","author":"P Chanana","year":"2017","unstructured":"Chanana P, Padhy G, Bhargava K, Arya R. Mutation in GNE downregulates Peroxiredoxin IV altering ER redox homeostasis. Neuromolecular Med. 2017. https:\/\/doi.org\/10.1007\/s12017-017-8467-5.","journal-title":"Neuromolecular Med"},{"key":"1377_CR7","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/jcb.30148","volume":"122","author":"P Chaudhary","year":"2021","unstructured":"Chaudhary P, Sharma S, Singh R, Arya R. Elucidation of ER stress and UPR pathway in Sialic acid-deficient cells: pathological relevance to GNEM. J Cell Biochem. 2021a;122:1886\u2013902.","journal-title":"J Cell Biochem"},{"key":"1377_CR8","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/jcb.30148","volume":"122","author":"P Chaudhary","year":"2021","unstructured":"Chaudhary P, Sharma S, Singh R, Arya R. Elucidation of ER stress and UPR pathway in Sialic acid-deficient cells: pathological relevance to GNEM. J Cell Biochem. 2021b;122:1886\u2013902. https:\/\/doi.org\/10.1002\/jcb.30148.","journal-title":"J Cell Biochem"},{"key":"1377_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx192","author":"A Cho","year":"2017","unstructured":"Cho A, Christine M, Malicdan V, et al. Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy. Hum Mol Genet. 2017. https:\/\/doi.org\/10.1093\/hmg\/ddx192.","journal-title":"Hum Mol Genet"},{"key":"1377_CR10","doi-asserted-by":"publisher","unstructured":"Co\u00ealho LCD, De Oliveira Cardoso MV, Moreira DRM, et al. Novel phthalimide derivatives with TNF-\u03b1 and IL-1\u03b2 expression inhibitory and apoptotic inducing properties. Medchemcomm. 2014;5. https:\/\/doi.org\/10.1039\/c4md00070f .","DOI":"10.1039\/c4md00070f"},{"key":"1377_CR11","doi-asserted-by":"publisher","DOI":"10.1039\/d1md00374g","author":"CJ Cristancho Ortiz","year":"2022","unstructured":"Cristancho Ortiz CJ, de Freitas Silva M, Pruccoli L, et al. Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation. RSC Med Chem. 2022. https:\/\/doi.org\/10.1039\/d1md00374g.","journal-title":"RSC Med Chem"},{"key":"1377_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.603742","author":"SS Devi","year":"2021","unstructured":"Devi SS, Yadav R, Arya R. Altered actin dynamics in cell migration of GNE mutant cells. Front Cell Dev Biol. 2021a. https:\/\/doi.org\/10.3389\/fcell.2021.603742.","journal-title":"Front Cell Dev Biol"},{"key":"1377_CR13","doi-asserted-by":"publisher","first-page":"603742","DOI":"10.3389\/fcell.2021.603742","volume":"9","author":"SS Devi","year":"2021","unstructured":"Devi SS, Yadav R, Arya R. Altered actin dynamics in cell migration of GNE mutant cells. Front Cell Dev Biol. 2021b;9:603742.","journal-title":"Front Cell Dev Biol"},{"key":"1377_CR14","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1007\/s12035-021-02549-w","volume":"58","author":"SS Devi","year":"2021","unstructured":"Devi SS, Yadav R, Mashangva F, et al. Generation and characterization of a skeletal muscle cell-based model carrying one single Gne allele: implications in actin dynamics. Mol Neurobiol. 2021c;58:6316\u201334. https:\/\/doi.org\/10.1007\/s12035-021-02549-w.","journal-title":"Mol Neurobiol"},{"key":"1377_CR15","doi-asserted-by":"publisher","DOI":"10.1021\/jm051256o","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006. https:\/\/doi.org\/10.1021\/jm051256o.","journal-title":"J Med Chem"},{"key":"1377_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12035-013-8604-6","volume":"50","author":"S Grover","year":"2014","unstructured":"Grover S, Arya R. Role of UDP-N-acetylglucosamine2-epimerase\/N-acetylmannosamine kinase (GNE) in \u03b21-integrin-mediated cell adhesion. Mol Neurobiol. 2014;50:257\u201373.","journal-title":"Mol Neurobiol"},{"key":"1377_CR17","doi-asserted-by":"publisher","DOI":"10.1021\/jm030644s","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004. https:\/\/doi.org\/10.1021\/jm030644s.","journal-title":"J Med Chem"},{"key":"1377_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103567","author":"SS Hamdani","year":"2020","unstructured":"Hamdani SS, Khan BA, Hameed S, et al. Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease. Bioorg Chem. 2020. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103567.","journal-title":"Bioorg Chem"},{"key":"1377_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/128_2013_464","volume":"366","author":"S Hinderlich","year":"2015","unstructured":"Hinderlich S, Weidemann W, Yardeni T, et al. UDP-GlcNAc 2-epimerase\/ManNAc kinase (GNE): A master regulator of Sialic acid synthesis. Top Curr Chem. 2015;366:97\u2013138. https:\/\/doi.org\/10.1007\/128_2013_464.","journal-title":"Top Curr Chem"},{"key":"1377_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2022.930110","author":"N Ilouz","year":"2022","unstructured":"Ilouz N, Harazi A, Guttman M, et al. In vivo and in vitro genome editing to explore GNE functions. Front Genome Ed. 2022. https:\/\/doi.org\/10.3389\/fgeed.2022.930110.","journal-title":"Front Genome Ed"},{"key":"1377_CR21","doi-asserted-by":"publisher","unstructured":"Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible Docking. J Mol Biol. 1997;267. https:\/\/doi.org\/10.1006\/jmbi.1996.0897.","DOI":"10.1006\/jmbi.1996.0897"},{"key":"1377_CR22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/ml3000148","volume":"3","author":"MR Kaller","year":"2012","unstructured":"Kaller MR, Harried SS, Albrecht B, et al. A potent and orally efficacious, hydroxyethylamine-based inhibitor of \u03b2-secretase. ACS Med Chem Lett. 2012;3:886\u201391. https:\/\/doi.org\/10.1021\/ml3000148.","journal-title":"ACS Med Chem Lett"},{"key":"1377_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2175382","author":"M Kashif","year":"2023","unstructured":"Kashif M, Subbarao N. Identification of potential novel inhibitors against glutamine synthetase enzyme of Leishmania major by using computational tools. J Biomol Struct Dyn. 2023. https:\/\/doi.org\/10.1080\/07391102.2023.2175382.","journal-title":"J Biomol Struct Dyn"},{"key":"1377_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00128","author":"NM Kocaturk","year":"2018","unstructured":"Kocaturk NM, Gozuacik D. Crosstalk between mammalian autophagy and the ubiquitin-proteasome system. Front Cell Dev Biol. 2018. https:\/\/doi.org\/10.3389\/fcell.2018.00128.","journal-title":"Front Cell Dev Biol"},{"key":"1377_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/ar000033j","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C, et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000. https:\/\/doi.org\/10.1021\/ar000033j.","journal-title":"Acc Chem Res"},{"key":"1377_CR26","doi-asserted-by":"publisher","unstructured":"Kumar S, Upadhyay C, Bansal M, et al. Experimental and computational studies of Microwave-Assisted, facile ring opening of epoxide with less reactive aromatic amines in nitromethane. ACS Omega. 2020;5. https:\/\/doi.org\/10.1021\/acsomega.0c01760.","DOI":"10.1021\/acsomega.0c01760"},{"key":"1377_CR27","doi-asserted-by":"crossref","unstructured":"Kumari R, Kumar R, Consortium OSDD, Lynn A. g_mmpbsa - A GROMACS tool for high-throughput for MM-PBSA calculations. J Chem Inf Model. 2014. https:\/\/pubs.acs.org\/doi\/full\/10.1021\/ci500020m.","DOI":"10.1021\/ci500020m"},{"key":"1377_CR28","doi-asserted-by":"publisher","DOI":"10.1021\/ci200227u","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB. Ligplot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011. https:\/\/doi.org\/10.1021\/ci200227u.","journal-title":"J Chem Inf Model"},{"key":"1377_CR29","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666171023163752","author":"ACL Leite","year":"2019","unstructured":"Leite ACL, Esp\u00edndola JWP, de Oliveira Cardoso MV, de Oliveira Filho GB. Privileged structures in the design of potential drug candidates for neglected diseases. Curr Med Chem. 2019. https:\/\/doi.org\/10.2174\/0929867324666171023163752.","journal-title":"Curr Med Chem"},{"key":"1377_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03050-2","author":"X Leleu","year":"2024","unstructured":"Leleu X, Hulin C, Lambert J, et al. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nat Med. 2024. https:\/\/doi.org\/10.1038\/s41591-024-03050-2.","journal-title":"Nat Med"},{"key":"1377_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.03.066","author":"W Li","year":"2018","unstructured":"Li W, Gao C, Zhao L, et al. Phthalimide conjugations for the degradation of oncogenic PI3K. Eur J Med Chem. 2018. https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.066.","journal-title":"Eur J Med Chem"},{"key":"1377_CR32","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000006932","volume":"92","author":"H Lochm\u00fcller","year":"2019","unstructured":"Lochm\u00fcller H, Behin A, Caraco Y, et al. A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy. Neurology. 2019a;92:e2109. https:\/\/doi.org\/10.1212\/WNL.0000000000006932.","journal-title":"Neurology"},{"key":"1377_CR33","doi-asserted-by":"publisher","unstructured":"Lochm\u00fcller H, Behin A, Caraco Y, et al. A phase 3 randomized study evaluating Sialic acid extended-release for GNE myopathy. Neurology. 2019b;92. https:\/\/doi.org\/10.1212\/WNL.0000000000006932.","DOI":"10.1212\/WNL.0000000000006932"},{"key":"1377_CR34","doi-asserted-by":"publisher","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27. https:\/\/doi.org\/10.1007\/s10822-013-9644-8.","DOI":"10.1007\/s10822-013-9644-8"},{"key":"1377_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/ddl446","volume":"16","author":"MCV Malicdan","year":"2007","unstructured":"Malicdan MCV, Noguchi S, Nonaka I, et al. A gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet. 2007;16:115\u201328.","journal-title":"Hum Mol Genet"},{"key":"1377_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1152\/physiolgenomics.90219.2008","volume":"35","author":"MCV Malicdan","year":"2008","unstructured":"Malicdan MCV, Noguchi S, Hayashi YK, Nishino I. Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of dmrv\/hibm. Physiol Genomics. 2008;35:106\u201315.","journal-title":"Physiol Genomics"},{"key":"1377_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116199","author":"F Mashangva","year":"2024","unstructured":"Mashangva F, Oswalia J, Singh S, Arya R. Potential small effector molecules restoring cellular defects due to Sialic acid biosynthetic enzyme deficiency: pathological relevance to GNE myopathy. Biochem Pharmacol. 2024a. https:\/\/doi.org\/10.1016\/j.bcp.2024.116199.","journal-title":"Biochem Pharmacol"},{"key":"1377_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-023-00414-7","author":"F Mashangva","year":"2024","unstructured":"Mashangva F, Singh S, Oswalia J, Arya R. Understanding pathophysiology of GNE myopathy and current progress towards drug development. J Biosci. 2024b. https:\/\/doi.org\/10.1007\/s12038-023-00414-7.","journal-title":"J Biosci"},{"key":"1377_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwae004","author":"CT Neu","year":"2024","unstructured":"Neu CT, Weilepp L, Bork K, et al. GNE deficiency impairs myogenesis in C2C12 cells and cannot be rescued by ManNAc supplementation. Glycobiology. 2024. https:\/\/doi.org\/10.1093\/glycob\/cwae004.","journal-title":"Glycobiology"},{"key":"1377_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114118","author":"J Oswalia","year":"2024","unstructured":"Oswalia J, Singh S, Gautam V, Arya R. Altered autophagic flux in GNE mutant cells of Indian origin: potential drug target for GNE myopathy. Exp Cell Res. 2024. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114118.","journal-title":"Exp Cell Res"},{"key":"1377_CR41","doi-asserted-by":"publisher","DOI":"10.3233\/JND-160154","author":"GK Papadimas","year":"2016","unstructured":"Papadimas GK, Evil\u00e4 A, Papadopoulos C, et al. GNE-myopathy in a Greek Romani family with unusual calf phenotype and protein aggregation pathology. J Neuromuscul Dis. 2016. https:\/\/doi.org\/10.3233\/JND-160154.","journal-title":"J Neuromuscul Dis"},{"key":"1377_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/00397911.2019.1614630","author":"PS Phatak","year":"2019","unstructured":"Phatak PS, Bakale RD, Dhumal ST, et al. Synthesis, antitubercular evaluation and molecular docking studies of phthalimide bearing 1,2,3-triazoles. Synth Commun. 2019. https:\/\/doi.org\/10.1080\/00397911.2019.1614630.","journal-title":"Synth Commun"},{"key":"1377_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-018-0802-x","volume":"13","author":"O Pogoryelova","year":"2018","unstructured":"Pogoryelova O, Gonz\u00e1lez Coraspe JA, Nikolenko N, et al. GNE myopathy: from clinics and genetics to pathology and research strategies. Orphanet J Rare Dis. 2018;13:70. https:\/\/doi.org\/10.1186\/s13023-018-0802-x.","journal-title":"Orphanet J Rare Dis"},{"key":"1377_CR44","doi-asserted-by":"publisher","unstructured":"REISSIG JL, STORMINGER JL, LELOIR LF. A modified colorimetric method for the Estimation of N-acetylamino sugars. J Biol Chem. 1955;217. https:\/\/doi.org\/10.1016\/s0021-9258(18)65959-9.","DOI":"10.1016\/s0021-9258(18)65959-9"},{"key":"1377_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-022-00238-3","author":"RE Schmitt","year":"2022","unstructured":"Schmitt RE, Smith DY, Cho DS, et al. Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy. NPJ Regen Med. 2022. https:\/\/doi.org\/10.1038\/s41536-022-00238-3.","journal-title":"NPJ Regen Med"},{"key":"1377_CR46","doi-asserted-by":"publisher","first-page":"e16334","DOI":"10.1371\/journal.pone.0016334","volume":"6","author":"I Sela","year":"2011","unstructured":"Sela I, Milman Krentsis I, Shlomai Z, et al. The proteomic profile of hereditary inclusion body myopathy. PLoS ONE. 2011;6:e16334.","journal-title":"PLoS ONE"},{"key":"1377_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biochi.2022.03.014","volume":"199","author":"S Sharma","year":"2022","unstructured":"Sharma S, Chanana P, Bharadwaj R, et al. Functional characterization of GNE mutations prevalent in Asian subjects with GNE myopathy, an ultra-rare neuromuscular disorder. Biochimie. 2022;199:36\u201345. https:\/\/doi.org\/10.1016\/j.biochi.2022.03.014.","journal-title":"Biochimie"},{"key":"1377_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1021\/ACSINFECDIS.8B00197\/SUPPL_FILE\/ID8B00197_SI_001.PDF","volume":"5","author":"S Singh","year":"2019","unstructured":"Singh S, Rajendran V, He J, et al. Fast-Acting small molecules targeting malarial aspartyl proteases, plasmepsins, inhibit malaria infection at multiple life stages. ACS Infect Dis. 2019;5:184\u201398. https:\/\/doi.org\/10.1021\/ACSINFECDIS.8B00197\/SUPPL_FILE\/ID8B00197_SI_001.PDF.","journal-title":"ACS Infect Dis"},{"key":"1377_CR48","doi-asserted-by":"publisher","unstructured":"Singh S, El-sakkary N, Skinner DE, et al. Synthesis and bioactivity of phthalimide analogs as potential drugs to treat schistosomiasis, a neglected disease of poverty. Pharmaceuticals. 2020;13. https:\/\/doi.org\/10.3390\/ph13020025.","DOI":"10.3390\/ph13020025"},{"key":"1377_CR50","doi-asserted-by":"publisher","DOI":"10.3233\/JND-230029","author":"N Suzuki","year":"2023","unstructured":"Suzuki N, Mori-Yoshimura M, Katsuno M, et al. Phase II\/III study of aceneuramic acid administration for GNE myopathy in Japan. J Neuromuscul Dis. 2023. https:\/\/doi.org\/10.3233\/JND-230029.","journal-title":"J Neuromuscul Dis"},{"key":"1377_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0049-9","author":"E Tambuyzer","year":"2020","unstructured":"Tambuyzer E, Vandendriessche B, Austin CP, et al. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov. 2020. https:\/\/doi.org\/10.1038\/s41573-019-0049-9.","journal-title":"Nat Rev Drug Discov"},{"key":"1377_CR52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41591-023-02703-y","volume":"30","author":"S Trudel","year":"2024","unstructured":"Trudel S, McCurdy A, Louzada ML, et al. Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1\/2 trial. Nat Med. 2024;30:543\u201351. https:\/\/doi.org\/10.1038\/s41591-023-02703-y.","journal-title":"Nat Med"},{"key":"1377_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6020045","author":"V Volloch","year":"2018","unstructured":"Volloch V, Rits S. Results of beta secretase-inhibitor clinical trials support amyloid precursor protein-independent generation of beta amyloid in sporadic Alzheimer\u2019s disease. Med Sci. 2018. https:\/\/doi.org\/10.3390\/medsci6020045.","journal-title":"Med Sci"},{"key":"1377_CR54","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016357811882","author":"R Wang","year":"2002","unstructured":"Wang R, Lai L, Wang S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput Aided Mol Des. 2002. https:\/\/doi.org\/10.1023\/A:1016357811882.","journal-title":"J Comput Aided Mol Des"},{"key":"1377_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106258","volume":"149","author":"R Yadav","year":"2022","unstructured":"Yadav R, Devi SS, Oswalia J, et al. Role of HSP70 chaperone in protein aggregate phenomenon of GNE mutant cells: therapeutic lead for GNE myopathy. Int J Biochem Cell Biol. 2022;149:106258.","journal-title":"Int J Biochem Cell Biol"},{"key":"1377_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/MINF.202400372","author":"V Yadav","year":"2025","unstructured":"Yadav V, Kashif M, Kamali Z, et al. In silico identification of novel and potent inhibitors against mutant BRAF (V600E), MD simulations, free energy calculations, and experimental determination of binding affinity. Mol Inform. 2025. https:\/\/doi.org\/10.1002\/MINF.202400372.","journal-title":"Mol Inform"},{"key":"1377_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012050","author":"F Zahedifard","year":"2024","unstructured":"Zahedifard F, Bansal M, Sharma N, et al. Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity. PLoS Negl Trop Dis. 2024. https:\/\/doi.org\/10.1371\/journal.pntd.0012050.","journal-title":"PLoS Negl Trop Dis"},{"key":"1377_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114958","author":"T Zhang","year":"2023","unstructured":"Zhang T, Yin X, Yu X, et al. Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK\/mTOR-independent pathway. Biomed Pharmacother. 2023. https:\/\/doi.org\/10.1016\/j.biopha.2023.114958.","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01377-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:37:24Z","timestamp":1764740244000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01377-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01377-1","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethicas approvaland consent to participate"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}